Sandoz is conducting a voluntary recall of 10 lots of its generic oral contraceptive IntrovaleŽ in the US, following a recent report of a packaging flaw. The probability of this packaging flaw causing serious adverse health consequences is remote and Sandoz is not aware of any reports of related adverse events.



Read More...